Studies on the design of a composition of gel for the treatment of inflammatory diseases of the joints
Keywords:combined gel, composition, preservatives, antimicrobial activity, nipagin, technology, inflammation of the joints
The aim: the aim of our work was to experimentally substantiate the effectiveness of antimicrobial preservatives in the design of the composition of the combined gel for the treatment of acute and chronic inflammation of the joints.
Methods: biological pharmacopoeial method of research was used (research of the effectiveness of antimicrobial preservatives).
Results. All drugs must meet the requirements of regulatory documents on indicators "Microbiological purity." To ensure the microbiological stability of the preparations, it is necessary to eliminate the factors associated with microbial contamination, therefore we carried out experimental studies on the choice of preservative and its concentration for the developed gel. According to the results of experimental studies on the effectiveness of antimicrobial preservatives in gel samples, the following data were obtained. Samples of the studied gel with sodium preservatives benzoate 0.5 % and nipagin 0.2 % meet the criterion "A" according to the requirements of SPHU for drugs for skin application. But, according to research results, the antimicrobial efficacy of the gel with the preservative nipagin 0.2 % was slightly higher (lg reduction in the number of viable Staphylococcus aureus ATCC 6538 cells was 3.32 and 4.81; Pseudomonas aeruginosa ATCC 9027 - 3.28 and 4.66 ; Candida albicans ATCC 885-653 - 3.50 and 4.09; Aspergillus brasiliensis ATCC 16404 - 3.10 and 4.00 (2 and 7 days, respectively) and the spectrum of antimicrobial action is wider, which will contribute to the quality of the rotated gel also during storage. Therefore, for further research, we will use nipagin 0.2 % as a preservative.
Conclusions: The expediency of using nipagin 0.2 % as a part of a combined gel for the treatment of acute and chronic joint inflammation has been theoretically proved and experimentally proved
Akao, T., Yoshino, T., Kobashi, K., Hattori, M. (2002). Evaluation of Salicin as an Antipyretic Prodrug that does not Cause Gastric Injury. Planta Medica, 68 (8), 714–718. doi: http://doi.org/10.1055/s-2002-33792
Bisset, N. G. (2004). Herbal Drugs and Phytopharmaceuticals. Stuttgart: Medpharm Scientific Publishers, 534–536.
Meier, F. M., Frerix, M., Hermann, W., Müller-Ladner, U. (2013). Current immunotherapy in rheumatoid arthritis. Immunotherapy, 5 (9), 955–974. doi: http://doi.org/10.2217/imt.13.94
Klimes, J., Vocelka, M., Sedova, L., Dolezal, T., Mlcoch, T., Petrikova, A., Vlcek, J. (2014). Medical and Productivity Costs of Rheumatoid Arthritis in The Czech Republic: Cost-of-Illness Study Based on Disease Severity. Value in Health Regional Issues, 4, 75–81. doi: http://doi.org/10.1016/j.vhri.2014.07.004
Postoi, V. V., Vyshnevska, L. I. (2017). Doslidzhennia z rozrobky skladu heliu dlia likuvannia revmatoidnoho artrytu. Kyiv, 2, 143.
Postoi, V. V., Vyshnevska, L. I. (2018). The marketing research of the Ukrainian market of drugs for the treatment of arthritis. News of Pharmacy, 1 (93), 38–42. doi: http://doi.org/10.24959/nphj.18.2198
Derzhavna Farmakopeia Ukrainy (2011). Kharkiv: Derzhavne pidpryiemstvo «Naukovo-ekspertnyi farmakopeinyi tsentr», RIREH, 536.
Derzhavna Farmakopeia Ukrainy Kharkiv. Vol. 1 (2015). Kharkiv: Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv», 1128.
Mirsonbol, S. Z., Issazadeh, K., Pahlaviani, M., Momeni, N. (2014). Antimicrobial efficacy of the methylparaben and benzoate sodium against selected standard microorganisms, clinical and environmental isolates in vitro. Indian Jornal of Fundamental and Applied Life Sciences, 4 (S4), 363–367.
Stanojevic, D. C. (2009). Antimicrobial effects of Sodium benzoate, Soium nitrate and Potassium sorbate and Their synergistic action in vitro. Bulgarian Journal of Agricultural Science, 15 (4), 307–311.
How to Cite
Copyright (c) 2018 Liliia Vyshnevska, Oksana Strilets, Postoy Vladyslav
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.